Pneumonia diagnostic algorithm

Revision as of 17:14, 23 February 2018 by Hamid Qazi (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumonia diagnostic algorithm On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumonia diagnostic algorithm

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumonia diagnostic algorithm

CDC onPneumonia diagnostic algorithm

Pneumonia diagnostic algorithm in the news

Blogs on Pneumonia diagnostic algorithm

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Pneumonia diagnostic algorithm

Diagnostic Algorithm

Shown below is an algorithm for the diagnostic approach of pneumonia.[1] [2]
Abbreviations: HCAP: Healthcare-associated pneumonia; CAP: Community-acquired pneumonia; VAP: Ventilator-associated pneumonia; HAP: Hospital-acquired pneumonia; AMT: Abbreviated mental test score

 
 
 
 
 
 
Symptoms that suggest a lower respiratory tract infection:
Fever
Cough with sputum
Dyspnea
Pleuritic chest pain
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order Labs:
Complete blood count (CBC)
Blood urea nitrogen (BUN)
Sputum gram stain and culture
Blood culture and ABG if necessary
If atypical pneumonia is suspected, obtain:
❑ Urine legionella antigen, rapid influenza test
Enyzme Immunoassay
Immunofluorescence
Polymerase chain reaction (PCR) for atypical and viral including influenza
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Order a chest X-ray if the patient presents with any of the following:[3]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient meets any of the following criteria for HCAP?[4]
  • Hospitalized in an acute care hospital for 2 or more days within 90 days of the infection;
  • Resided in a nursing home or long-term care facility;
  • Received recent intravenous antibiotic therapy, chemotherapy, or wound care within the past 30 days of the current infection;
  • Attended a hospital or hemodialysis clinic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
NO
The patient has CAP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the infection occurred ≥48 hours after admission and it was not present at admission?
 
 
 
 
Does the patient has at least 2 of the following CURB65 criteria?
  • Confusion (AMT ≤8)
  • Urea greater than 7 mmol/l (BUN > 20)
  • Respiratory rate ≥ 30 breaths/min
  • Blood pressure ≤ 90 systolic or ≤ 60 diastolic
  • Age 65 or older
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES

If the patient had an endotracheal tube placed ≥48 hours ago, suspect VAP. Otherwise, the patient has HAP
 
NO

The patient has HCAP
 
YES

Admit the patient and administer empiric inpatient antibiotic regimen
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

CURB-65 Clinical Prediction Rule

CURB-65 is a clinical prediction rule that has been validated for predicting mortality in community-acquired pneumonia[5] and infection of any site[6]. The CURB-65 is based on the earlier CURB score[7] and is recommended by the British Thoracic Society for the assessment of severity of pneumonia.[8]

Calculation of CURB-65

The score is an acronym for each of the risk factors measured. Each risk factor scores one point, for a maximum score of 5:

Criteria Score
Confusion (defined as an AMT of 8 or less) 1
Urea greater than 7 mmol/l (Blood Urea Nitrogen > 20) 1
Respiratory rate of 30 breaths per minute or greater 1
Blood pressure less than 90 systolic or diastolic blood pressure 60 or less 1
Age 65 or older 1

Interpretation of CURB-65: Risk of Death from Pneumnoia

The risk of death increases as the score increases.

CURB-65 Score Risk of death
0 0.7%
1 3.2%
2 13.0%
3 17.0%
4 41.5%
5 57.0%

The CURB-65 has been compared to the pneumonia severity index in predicting mortality from pneumonia.[9]

Interpretation of CURB-65: Risk of Death from any Infection

A cohort study of patients with any type of infection (half of the patients had pneumonia), the risk of death increases as the score increases[6]:

  • 0 to 1 <5% mortality
  • 2 to 3 < 10% mortality
  • 4 to 5 15-30% mortality

References

  1. Mandell, L. A.; Wunderink, R. G.; Anzueto, A.; Bartlett, J. G.; Campbell, G. D.; Dean, N. C.; Dowell, S. F.; File, T. M.; Musher, D. M.; Niederman, M. S.; Torres, A.; Whitney, C. G. (2007). "Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults". Clinical Infectious Diseases. 44 (Supplement 2): S27–S72. doi:10.1086/511159. ISSN 1058-4838.
  2. Solomon, Caren G.; Wunderink, Richard G.; Waterer, Grant W. (2014). "Community-Acquired Pneumonia". New England Journal of Medicine. 370 (6): 543–551. doi:10.1056/NEJMcp1214869. ISSN 0028-4793.
  3. Watkins RR, Lemonovich TL (2011). "Diagnosis and management of community-acquired pneumonia in adults". Am Fam Physician. 83 (11): 1299–306. PMID 21661712.
  4. Attridge RT, Frei CR (2011). "Health care-associated pneumonia: an evidence-based review". The American Journal of Medicine. 124 (8): 689–97. doi:10.1016/j.amjmed.2011.01.023. PMID 21663884. Retrieved 2012-09-02. Unknown parameter |month= ignored (help)
  5. Lim WS, van der Eerden MM, Laing R; et al. (2003). "Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study". Thorax. 58 (5): 377–82. PMID 12728155.
  6. 6.0 6.1 Howell MD, Donnino MW, Talmor D, Clardy P, Ngo L, Shapiro NI (2007). "Performance of severity of illness scoring systems in emergency department patients with infection". Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 14 (8): 709–14. doi:10.1197/j.aem.2007.02.036. PMID 17576773.
  7. Lim WS, Macfarlane JT, Boswell TC; et al. (2001). "Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines". Thorax. 56 (4): 296–301. PMID 11254821.
  8. "BTS Guidelines for the Management of Community Acquired Pneumonia in Adults". Thorax. 56 Suppl 4: IV1–64. 2001. PMID 11713364.
  9. Aujesky D, Auble TE, Yealy DM; et al. (2005). "Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia". Am. J. Med. 118 (4): 384–92. doi:10.1016/j.amjmed.2005.01.006. PMID 15808136.